Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

HALO Q1 Conference Call May 9 at 4:30PM ET.

http://www.halozyme.com/investors/news-releases/news-release-details/2017/Halozyme-To-Host-First-Quarter-2017-Financial-Results-Conference-Call/default.aspx

Halozyme To Host First Quarter 2017 Financial Results Conference Call


04/10/2017
SAN DIEGO, April 10, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the first quarter 2017 on Tues., May 9 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the same date, Halozyme will release financial results for the first quarter 2017 following the close of trading.

The call will be webcast live through the "Investors" section of Halozyme's corporate website and a recording will be made available following the close of the call. To access the webcast and additional documents related to the call, please visit the Investors page of www.halozyme.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. The live call may be accessed by calling [phone] (domestic callers) or [phone] (international callers) using passcode 769890. A telephone replay will be available after the call by dialing [phone] (domestic callers) or [phone] (international callers) using replay ID number 22142823.

- See more at: http://www.halozyme.com/investors/news-releases/news-release-details/2017/Halozyme-To-Host-First-Quarter-2017-Financial-Results-Conference-Call/default.aspx#sthash.TOFlUPw1.dpuf